Ivey Publishing

Product Details

Medicare and Drug-eluting Stents
Product Number:
9B05M053
Publication Date:
03/01/2006
Revised Date:
10/01/2009
Length:
12 pages (7 pages of text)
Product Type:
Case (Library)
Source:
Ivey
The U.S. Food and Drug Administration has recently approved a drug-coated stent for use in angioplasty procedures. The stent is expected to reduce the rate of repeat procedures due to restenosis, and to postpone the need for more invasive surgery such as coronary bypass. However, the drug-coated stent costs three times as much as an uncoated stent, which will increase the cost of the medical procedure. Public demand for the stent is overwhelming, because of the higher cost and huge demand, cost of medical care could increase dramatically. Students need to think about the trade-off between quality improvements and higher costs of medical treatment by looking at the impact on several stakeholders: patients, hospitals and insurers.
Issues:
Disciplines:
General Management/Strategy
Industries:
Health Care Services
Setting:
United States, 2003
Intended Audience:
MBA/Postgraduate
Price:
$5.30 CAD / $5.00 USD Printed Copy
$4.50 CAD / $4.25 USD Permissions
$4.50 CAD / $4.25 USD Digital Download
You Might Also Like...

Save In: